Dongkoo Bio&Pharma to be listed in KOSDAQ market after forecasting demands and subscribing

Dongkoo Bio&Pharma will go public in the middle of February after forecasting demands between 30 and 31 January and subscribing between 5 and 6 February. The organization of the listing is NH Investment & Securities.

Dongkoo Bio&Pharma, the largest prescription pharmaceutical company in the dermatologic field,  has entered the global market by developing ‘SmartX,’ the world’s first and only st...